Applicant, as named in the Orange Book

Paratek Pharms

Next listed expiry: Xhance on 23 Feb 2036. 3 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	Earliest generic entry	Basis
Xhance NDA 209022 fluticasone propionate	fluticasone propionate	23 Feb 2036 patent, carve-out possible	patent, carve-out possible
Nuzyra NDA 209816 omadacycline tosylate	omadacycline tosylate	31 Oct 2037 patent, carve-out possible	patent, carve-out possible
Nuzyra NDA 209817 omadacycline tosylate	omadacycline tosylate	31 Oct 2037 patent, carve-out possible	patent, carve-out possible

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.